Autopsy report · NCT03290053

Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S)

“Poor inclusion rate \& lack of funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 5 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Umeå University

Sponsor type

University, hospital or other

Conditions

Ischemic Stroke

Interventions

SonoVue; Sodium chloride; Transcranial Ultrasound; Sham Transcranial Ultrasound

Participants

1

Sites

1

Countries

Sweden

Trials that died the same way

• Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
  “Lack of financial support and low inclusion rate” (86% match in meaning)
• Dexmedetomidine Pharmacokinetics-pharmacodynamics in Mechanically Ventilated Children With Single-organ Respiratory Failure
  “Poor inclusion rate.” (81% match in meaning)
• Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
  “lack of funding/ benefit” (73% match in meaning)
• Systematic Work Environment Model Incorporating Web-based Neck-specific Exercise for Dental Staff With Neck Pain
  “Lack of fundings” (71% match in meaning)
• Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis Patients
  “Lack of funding” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.